Raymond James Financial Inc. purchased a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free ...

StockNews.com initiated coverage on shares of bluebird bio (NASDAQ:BLUE – Free Report) in a report published on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. A ...

A Durham company is pushing back on media reports questioning the safety of its lead product as the firm begins its commercial launch.

Northwest Biotherapeutics Inc. can proceed with claims against seven firms including Citadel Securities and Virtu Americas LLC for depressing the company’s stock price through false sale orders, a ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Beam Therapeutics BEAM has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives ...

Shanghai Henlius Biotech and Organon (OGN) announced that the European Medicines Agency has validated the marketing authorization application ...

Learn more about whether Alvotech or Merus N.V. is a better investment based on AAII's A+ Investor grades, which compare both ...

Portage Biotech have more than doubled in the after-hours market after the company reported preclinical results for PORT-7 in a murine mesothelioma model. In the Thursday late trading session, the ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

JP Morgan sees strong growth for Ascentage Pharma, citing its late-stage cancer drugs. The biotech's 2024 sales surged 342% ...

Investors’ deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approvals and M&A.